电针干预通过调节NMDAR1和GABABR1来改善中风后的消化不良
Jinjin Wang1,2, Qinqin Ma1, Fang Li1
1Department of Rehabilitation Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Current neurovascular research
|August 13, 2025
概括
电针 (EA) 刺激通过改善神经元损伤和平衡特定受体,有效地治疗中风后 (PSD). 本研究阐明了EA背后的机制.
科学领域:
- 神经科学是一个神经科学.
- 针研究 针研究
- 脑卒中康复治疗 脑卒中康复治疗
背景情况:
- 脑卒中后失消症 (PSD) 是急性中风后的常见并发症.
- 电针 (EA) 在Baihui针点的刺激显示出减轻PSD的希望,但其机制尚未完全理解.
研究的目的:
- 研究EA刺激的治疗机制在Baihui针点治疗中风后失足症 (PSD).
- 评估EA对神经功能,脑梗塞,和氧化应激在中风的小鼠模型的影响.
主要方法:
- 建立了一个中脑动脉阻塞 (MCAO) 鼠标模型来诱导中风.
- 对白针点进行EA刺激,随后对生存率,吞功能,神经学分数和血清Ca2+-Mg2+-ATPase活性进行评估.
- 磁共振成像 (MRI) 评估了脑梗塞和,同时测量了氧化应激标志物.
- 西方斑块,RT-qPCR和免疫光检测出了胺黄油酸B型受体子单元1 (GABABR1) 和N-甲基-D-酸盐受体1 (NMDAR1) 的表达.
主要成果:
- 在MCAO小鼠中,EA干预显著增加了生存率,并减轻了食障碍.
- 神经功能得到改善,EA治疗后脑梗塞和的发生率下降.
- EA降低了氧化应激,保护了核中的神经元模糊,调高了GABABR1和调低了NMDAR1.
结论:
- 在治疗PSD方面,EA对Baihui针点的刺激是有效的.
- 治疗效果与改善神经元完整性和平衡表达GABABR1和NMDAR1.1有关.
- 这些发现为EA对PSD的机制提供了新的见解,并为未来的临床研究提供了基础.
相关概念视频
01:37Neural Regulation
34.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.8K
01:26Neurochemical Transmission: Sites of Drug Action
3.5K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.5K
01:23Drugs Acting on Autonomic Ganglia: Stimulants
2.2K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.2K
01:27CNS Depressants: Alcohol and Nicotine
1.7K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.7K
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
2.0K
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
2.0K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
820
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
820